Mellowing Mind: Comparing Two Technology Based Mindfulness Interventions for Stress Impacted by COVID-19 in Underserved Communities
Comparing Two Ways to Mitigate the Impact of the COVID-19 Pandemic on Mental Health Among Adults From Underserved and Racial Minority Communities
1 other identifier
interventional
270
1 country
1
Brief Summary
The purpose of this study is to examine the comparative effectiveness of two technology-based Mindfulness Based Stress Reduction (MBSR) programs (one via video/teleconference and one via a smartphone app) for reducing worry, anxiety and/or related mental health effects of stress in members of identified underserved communities, which were highly impacted by the COVID-19 pandemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2021
CompletedFirst Submitted
Initial submission to the registry
May 19, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedSeptember 20, 2024
September 1, 2024
3.1 years
May 19, 2021
September 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Worry from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
A total score on the Penn State Worry Questionnaire \[PSWQ\], a scaled measure with total scores ranging from 16 to 80, in which higher scores indicate greater severity of worry
21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
Secondary Outcomes (9)
Changes in Anxiety from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
Changes in Perceived Stress from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
Changes in Depression from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
Changes in Sleep Quality from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
21 weeks Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
Changes in Loneliness from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention
21 Weeks Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention
- +4 more secondary outcomes
Study Arms (3)
Teleconference Mindfulness Intervention Group
OTHERMBSR training program that has been adapted for use via Zoom teleconferencing and for cultural relevancy
Smartphone App Mindfulness Intervention Group
OTHERMBSR training program that has been adapted for use via smartphone app and for cultural relevancy
Waitlist Control Group
NO INTERVENTIONNo intervention; control group
Interventions
The teleconference intervention is administered by a trained interventionist via Zoom and is based on a manual adapted from a traditional MBSR version. Practices and activities include meditations, mindful breathing exercises and movements, discussions, and reflections, which participants learn at weekly sessions and practice on their own throughout the week. To adapt the traditional MBSR program for the target community population, intervention materials were reviewed for feedback from community stakeholders, and modified according to their feedback.
The smartphone app intervention is administered through the app. The smartphone app aligns with the traditional MBSR format, but training and practice is done individually and independently by members of this group. To adapt the traditional MBSR program for the target community population, the app was tested by community stakeholders and modified according to their feedback.
Eligibility Criteria
You may qualify if:
- years and older
- Significant worry as per the Penn State Worry Questionnaire-Abbreviated \[PSWQ-A\]
- Fluent in English
- Reside in one of the local city zip codes, identified as underserved, and primarily African American, communities
You may not qualify if:
- Severe depression as per Patient Health Questionnaire \[PHQ-9\]
- Active suicidal intent as per PHQ-9 question 9
- Diagnosis of psychosis, or bipolar disorder, or moderate or severe substance use disorder in the past month as per self report
- Cognitive impairment as per (modified) Short Portable Mental Status Questionnaire \[SPMSQ\]
- Currently receiving psychotherapy or behavioral counseling, including MBSR
- Change in psychotropic medications within the last month as per self report
- Unable to communicate in a way that would allow for participation in screenings or sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
State University of New York, University at Buffalo
Buffalo, New York, 14214, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Yu-Ping Chang, PhD
SUNY at Buffalo School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Professor and Associate Dean for Research and Scholarship
Study Record Dates
First Submitted
May 19, 2021
First Posted
January 6, 2022
Study Start
May 14, 2021
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
September 20, 2024
Record last verified: 2024-09